These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 22890803

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study.
    Lyons K, Seghers V, Sorensen JI, Zhang W, Paldino MJ, Krishnamurthy R, Rohren EM.
    AJR Am J Roentgenol; 2015 Nov; 205(5):1094-101. PubMed ID: 26496558
    [Abstract] [Full Text] [Related]

  • 3. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C, Mai EK, Goldschmidt H, Hillengass J, Hose D, Pan L, Haberkorn U, Dimitrakopoulou-Strauss A.
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis.
    Tanaka S, Ikeda K, Uchiyama K, Iwamoto T, Sanayama Y, Okubo A, Nakagomi D, Takahashi K, Yokota M, Suto A, Suzuki K, Nakajima H.
    Rheumatology (Oxford); 2013 Jul; 52(7):1271-8. PubMed ID: 23479721
    [Abstract] [Full Text] [Related]

  • 6. Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors.
    Huang YE, Chen CF, Huang YJ, Konda SD, Appelbaum DE, Pu Y.
    Acta Radiol; 2010 Sep; 51(7):782-8. PubMed ID: 20707663
    [Abstract] [Full Text] [Related]

  • 7. FDG PET/CT in Crohn's disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity.
    Saboury B, Salavati A, Brothers A, Basu S, Kwee TC, Lam MG, Hustinx R, Louis E, Torigian DA, Alavi A.
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):605-14. PubMed ID: 24253895
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L, Nicolai E, Luongo A, Aiello M, Catalano OA, Soricelli A, Salvatore M.
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.
    Teo BK, Badiee S, Hadi M, Lam T, Johnson L, Seo Y, Bacharach SL, Hasegawa BH, Franc BL.
    Nucl Med Commun; 2008 Apr; 29(4):359-66. PubMed ID: 18317301
    [Abstract] [Full Text] [Related]

  • 17. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.
    Minamimoto R, Mosci C, Jamali M, Barkhodari A, Habte F, Jackson T, Mittra E, Gambhir SS, Iagaru A.
    J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978
    [Abstract] [Full Text] [Related]

  • 18. Cystic fibrosis: detecting changes in airway inflammation with FDG PET/CT.
    Amin R, Charron M, Grinblat L, Shammas A, Grasemann H, Graniel K, Ciet P, Tiddens H, Ratjen F.
    Radiology; 2012 Sep; 264(3):868-75. PubMed ID: 22829680
    [Abstract] [Full Text] [Related]

  • 19. Normal FDG distribution patterns in the head and neck: PET/CT evaluation.
    Nakamoto Y, Tatsumi M, Hammoud D, Cohade C, Osman MM, Wahl RL.
    Radiology; 2005 Mar; 234(3):879-85. PubMed ID: 15734938
    [Abstract] [Full Text] [Related]

  • 20. Effects of a proton pump inhibitor on the physiological accumulation of fluoro-2-deoxy-D-glucose (FDG) in FDG-positron emission tomography.
    Domeki Y, Yamazaki E, Matsuura A, Kitajima K, Murakami K, Kato H.
    Surg Today; 2012 Oct; 42(10):927-33. PubMed ID: 22825654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.